Celera has a successful molecular diagnostics business and powerful genomic and proteomic discovery platforms that have identified and validated new drug targets and biomarkers that will advance the practice of Targeted Medicine.
Celsense is a biotechnology company offering novel MRI contrast agents (fluorochemical nanoparticles) that allow scientists and clinicians to monitor the position and quantity of transplanted cells non-invasively in vivo.
Ceramatec has produced many proprietary materials for device fabrication such as castable nanoceramics. The company also synthesizes nano-powders using a proprietary powder synthesis process that results in very high purity, high-quality, un-agglomerated, high surface area, nanocrystalline ceramic powders.
Ceres uses its Nanotrap technology - a spherical, carbon-based nanoparticle designed to collect, concentrate, isolate and preserve the smallest and scarcest of molecules found in body fluids - to pursue a range of applications in the diagnosis and treatment of diseases, as well as uses in sports screening, homeland security and environmental remediation.
Develops technologies for the production and application of nanomaterials for a broad range of end uses - advanced simulation software, collaborative R&D, and consultation services for the analysis, design and optimization of nanomaterial fabrication processes. CFSRC's simulation tools enable rapid screening of concepts for both production and use of nanomaterials, optimization of downselected designs and processes, and rapid product development.
The company acquired substantially all of the assets of SouthWest NanoTechnologies (SWeNT) and has reopened the state-of-the-art Carbon Nanotube (CNT) plant in Norman, Oklahoma. They manufacture high-quality single-wall and few-wall CNT materials made using the patented CoMoCAT™ process under an exclusive license with the University of Oklahoma.